Bio Medica Labs. Stock Price Analysis and Quick Research Report. Is Bio Medica Labs. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Bio Medica Labs.. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Bio Medica Labs. has a PE ratio of 18.1148256560366 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Bio Medica Labs. has ROA of 33.6002% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Bio Medica Labs. has a Current ratio of 1.8295.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Bio Medica Labs. has a ROE of 99.5867%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Bio Medica Labs. has a Debt to Equity ratio of 1.0191 which means that the company has low proportion of debt in its capital.

• Sales growth: Bio Medica Labs. has reported revenue growth of 150.4702% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Bio Medica Labs. for the current financial year is 40.2477274631367%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Bio Medica Labs. is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Bio Medica Labs. is Rs 7.7892. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Bio Medica Labs. in Ticker for free. Also, one can get the intrinsic value of Bio Medica Labs. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Bio Medica Labs. FAQs

Q1. What is Bio Medica Labs. share price today?
Ans: The current share price of Bio Medica Labs. is Rs 141.1.

Q2. What is the market capitalisation of Bio Medica Labs.?
Ans: Bio Medica Labs. has a market capitalisation of Rs 177.43326411 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Bio Medica Labs.?
Ans: The PE ratio of Bio Medica Labs. is 18.1148256560366 and the P/B ratio of Bio Medica Labs. is 2.86536442521115, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Bio Medica Labs. share?
Ans: The 52-week high share price of Bio Medica Labs. is Rs 148, and the 52-week low share price of Bio Medica Labs. is Rs 101.5.

Q5. Does Bio Medica Labs. pay dividends?
Ans: Currently, Bio Medica Labs. does not pay dividends. Dividend yield of Bio Medica Labs. is around 0%.

Q6. What are the face value and book value of Bio Medica Labs. shares?
Ans: The face value of Bio Medica Labs. shares is Rs 10, while the book value per share of Bio Medica Labs. is around Rs 49.2433. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Bio Medica Labs.?
Ans: Bio Medica Labs. has a total debt of Rs 15.0144 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Bio Medica Labs.?
Ans: The ROE of Bio Medica Labs. is 99.5867% and ROCE of Bio Medica Labs. is 64.1814%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Bio Medica Labs. a good buy for the long term?
Ans: The Bio Medica Labs. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Bio Medica Labs. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Bio Medica Labs. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Bio Medica Labs.’s financials?
Ans: You can review Bio Medica Labs.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.